Analyzing SomaLogic (NASDAQ:SLGC) and Auxly Cannabis Group (OTCMKTS:CBWTF)

SomaLogic (NASDAQ:SLGCGet Rating) and Auxly Cannabis Group (OTCMKTS:CBWTFGet Rating) are both small-cap business services companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, profitability, analyst recommendations, valuation and dividends.

Institutional & Insider Ownership

58.7% of SomaLogic shares are held by institutional investors. Comparatively, 0.0% of Auxly Cannabis Group shares are held by institutional investors. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Analyst Recommendations

This is a summary of current recommendations and price targets for SomaLogic and Auxly Cannabis Group, as reported by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SomaLogic 0 0 4 0 3.00
Auxly Cannabis Group 0 1 2 0 2.67

SomaLogic currently has a consensus price target of $13.00, indicating a potential upside of 168.04%. Auxly Cannabis Group has a consensus price target of $0.50, indicating a potential upside of 792.86%. Given Auxly Cannabis Group’s higher probable upside, analysts plainly believe Auxly Cannabis Group is more favorable than SomaLogic.

Earnings & Valuation

This table compares SomaLogic and Auxly Cannabis Group’s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
SomaLogic $81.63 million 10.83 -$87.55 million N/A N/A
Auxly Cannabis Group $66.88 million 0.76 -$26.92 million ($0.07) -0.80

Auxly Cannabis Group has lower revenue, but higher earnings than SomaLogic.


This table compares SomaLogic and Auxly Cannabis Group’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
SomaLogic N/A -20.87% -16.08%
Auxly Cannabis Group -64.13% -34.98% -18.05%

Volatility and Risk

SomaLogic has a beta of 1.38, meaning that its stock price is 38% more volatile than the S&P 500. Comparatively, Auxly Cannabis Group has a beta of 0.79, meaning that its stock price is 21% less volatile than the S&P 500.


SomaLogic beats Auxly Cannabis Group on 9 of the 11 factors compared between the two stocks.

About SomaLogic

(Get Rating)

SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex protein detection and quantification of protein levels in complex biological samples. The company's SOMAmers/SomaScan technology enables researchers to analyze various types of biological samples for protein biomarker signatures, which can be utilized in drug discovery and development. Its SomaScan's biomarker discoveries help in diagnostic applications in various areas of diseases, including cardiovascular and metabolic disease, nonalcoholic steatohepatitis, wellness, and others. The company also provides SomaSignal research use only and laboratory-developed tests. It serves research and clinical customers with a focus on pharmaceutical and biotechnology companies, and academic research institutions, as well as facilitates drug development, analysis of clinical trials, and new human biology insights by assessing protein-protein and protein-gene networks. The company was incorporated in 1999 and is headquartered in Boulder, Colorado.

About Auxly Cannabis Group

(Get Rating)

Auxly Cannabis Group Inc. operates as a consumer-packaged goods company in the cannabis products market in Canada. The company focuses on developing, manufacturing, and distributing cannabis products for wellness and recreational consumers. It offers cannabis products under various forms, including vape catridges, dried flower, concentrates, chocolates, soft chews, oil drops, capsules, topicals, and hard candy under the brands KOLAB PROJECT, Dosecann, BACK FORTY, and Foray. The company was formerly known as Cannabis Wheaton Income Corp. and changed its name to Auxly Cannabis Group Inc. in June 2018. Auxly Cannabis Group Inc. was incorporated in 1987 and is based in Toronto, Canada.

Receive News & Ratings for SomaLogic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SomaLogic and related companies with's FREE daily email newsletter.